363 related articles for article (PubMed ID: 18346951)
1. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
2. Adamts1 is highly induced in rachitic bones of FGF23 transgenic mice and participates in degradation of non-mineralized bone matrix collagen.
Hu L; Andersson G; Jonsson KB; Melhus H; Lind T
Biochem Biophys Res Commun; 2013 Jan; 430(3):901-6. PubMed ID: 23261447
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
4. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
5. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K.
Kiviranta R; Morko J; Uusitalo H; Aro HT; Vuorio E; Rantakokko J
J Bone Miner Res; 2001 Aug; 16(8):1444-52. PubMed ID: 11499867
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein is required for normal intramembranous bone development.
Suda N; Baba O; Udagawa N; Terashima T; Kitahara Y; Takano Y; Kuroda T; Senior PV; Beck F; Hammond VE
J Bone Miner Res; 2001 Dec; 16(12):2182-91. PubMed ID: 11760831
[TBL] [Abstract][Full Text] [Related]
7. Histochemical evidence of osteoclastic degradation of extracellular matrix in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells.
Li M; Amizuka N; Takeuchi K; Freitas PH; Kawano Y; Hoshino M; Oda K; Nozawa-Inoue K; Maeda T
Microsc Res Tech; 2006 Feb; 69(2):73-83. PubMed ID: 16456838
[TBL] [Abstract][Full Text] [Related]
8. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
[TBL] [Abstract][Full Text] [Related]
10. Osteoclast size heterogeneity in rat long bones is associated with differences in adhesive ligand specificity.
Hu Y; Ek-Rylander B; Karlström E; Wendel M; Andersson G
Exp Cell Res; 2008 Feb; 314(3):638-50. PubMed ID: 18086469
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.
Delaissé JM; Andersen TL; Engsig MT; Henriksen K; Troen T; Blavier L
Microsc Res Tech; 2003 Aug; 61(6):504-13. PubMed ID: 12879418
[TBL] [Abstract][Full Text] [Related]
12. Cartilage abnormalities are associated with abnormal Phex expression and with altered matrix protein and MMP-9 localization in Hyp mice.
Miao D; Bai X; Panda DK; Karaplis AC; Goltzman D; McKee MD
Bone; 2004 Apr; 34(4):638-47. PubMed ID: 15050894
[TBL] [Abstract][Full Text] [Related]
13. Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts.
Zimmerman D; Jin F; Leboy P; Hardy S; Damsky C
Dev Biol; 2000 Apr; 220(1):2-15. PubMed ID: 10720426
[TBL] [Abstract][Full Text] [Related]
14. Correlation of an osteoclast antigen and ruffled border on giant cells formed in response to resorbable substrates.
Webber D; Osdoby P; Hauschka P; Krukowski M
J Bone Miner Res; 1990 Apr; 5(4):401-10. PubMed ID: 2343780
[TBL] [Abstract][Full Text] [Related]
15. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone.
Dai XM; Zong XH; Akhter MP; Stanley ER
J Bone Miner Res; 2004 Sep; 19(9):1441-51. PubMed ID: 15312244
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency.
Schiltz C; Marty C; de Vernejoul MC; Geoffroy V
J Cell Biochem; 2008 Aug; 104(5):1803-17. PubMed ID: 18384129
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro.
Wang H; Yoshiko Y; Yamamoto R; Minamizaki T; Kozai K; Tanne K; Aubin JE; Maeda N
J Bone Miner Res; 2008 Jun; 23(6):939-48. PubMed ID: 18282132
[TBL] [Abstract][Full Text] [Related]
18. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
[TBL] [Abstract][Full Text] [Related]
19. Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro.
Zhang W; Pantschenko AG; McCarthy MB; Gronowicz G
Calcif Tissue Int; 2007 Feb; 80(2):111-22. PubMed ID: 17308993
[TBL] [Abstract][Full Text] [Related]
20. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro.
Huang J; Yuan L; Wang X; Zhang TL; Wang K
Life Sci; 2007 Aug; 81(10):832-40. PubMed ID: 17764702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]